Product Images Losartan Potassium 25 Mg

This is a label of NuCare Pharmaceuticals, Inc. Losartan Potassium 25mg tablets with Lot# 000000 and expiration date are being manufactured and distributed. The label contains information about the manufacturer, product number, ingredients, and warnings about the product.*

The text is describing a study or clinical trial that involves testing the effectiveness of two drugs, Atenolol and Sartan Potassium, in treating a primary medical condition. The percentage of patients who achieved the primary endpoint of the study is not available. However, it provides information on Adjusted Risk Reduction, which is 13% and the p-value for statistical significance is 0.021. The study was conducted for a total of 66 months, with data being collected at several intervals ranging from 6 to 66 months.*

The text is not available as it is incomplete and doesn't provide any contextual meaning.*

The text describes the results of a study comparing the effects of Losartan Potassium and Atenolol on stroke rate and hazard ratio in different patient populations based on age, gender, race, diabetes, and history of cardiovascular disease. The study reports the number of events (fatal/non-fatal strokes) and hazard ratios in each group.*

This is a description of some statistical analysis regarding the reduction of risk in an unknown field. The analysis shows a reduction of 16.1% and the p-value is 0.022. There are also two graphs showing the percentage of patients with an event, but the context and meaning are missing.*